Toshihiko Okazaki
- Immunology top 2%
- Molecular Biology top 10%
- Oncology top 10%
- Genetics top 5%
- Cancer Research top 10%
- Co-authors
- Osamu TakeuchiShizuo AkiraTakashi SatohKoubun YasudaKiri HonmaKazufumi MatsushitaToru MiyakeKatsuyuki Yui
- Topics
- Virus-based gene therapy research (4 papers)Inflammatory Bowel Disease (4 papers)Immunotherapy and Immune Responses (4 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Toshihiko Okazaki
26 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Immunology 930
- Molecular Biology 737
- Oncology 352
- Genetics 343
- Cancer Research 264
Countries citing papers authored by Toshihiko Okazaki
This map shows the geographic impact of Toshihiko Okazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihiko Okazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihiko Okazaki more than expected).
Fields of papers citing papers by Toshihiko Okazaki
This network shows the impact of papers produced by Toshihiko Okazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihiko Okazaki. The network helps show where Toshihiko Okazaki may publish in the future.
Co-authorship network of co-authors of Toshihiko Okazaki
This figure shows the co-authorship network connecting the top 25 collaborators of Toshihiko Okazaki. A scholar is included among the top collaborators of Toshihiko Okazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshihiko Okazaki. Toshihiko Okazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 1 | |
| 3 | 13 | |
| 4 | 35 | |
| 5 | 15 | |
| 6 | 11 | |
| 7 | 19 | |
| 8 | 188 | |
| 9 | 8 | |
| 10 | 30 | |
| 11 | The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infectionbreakdown → | 926 |
| 12 | 6 | |
| 13 | 57 | |
| 14 | 7 | |
| 15 | 34 | |
| 16 | 1 | |
| 17 | 289 | |
| 18 | 178 | |
| 19 | 1 | |
| 20 | [Effect of medroxyprogesterone acetate on side effects of CAP therapy in gynecological malignant tumors]. | 2 |
About Toshihiko Okazaki
Toshihiko Okazaki is a scholar working on Immunology, Gastroenterology and Genetics, having authored 26 papers that have together received 1.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Inflammatory Bowel Disease (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Immunology (930 citations), Gastroenterology (188 citations) and Cancer Research (264 citations). Toshihiko Okazaki has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Osamu Takeuchi, Shizuo Akira, Takashi Satoh, Koubun Yasuda, Kiri Honma, Kazufumi Matsushita, Toru Miyake, Katsuyuki Yui, Tatsuya Saitoh and Kenji Nakanishi. Their work appears in journals such as Nature Immunology, The Journal of Immunology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.